Burcon Announces Year-End Results, Reviews Operations - Page 6

GlobeNewswire
Share
Monday, June 25th 2012
Advanced
class="gnw_label">    Deferred revenue   222,656  --           1,139,308  1,328,920        Shareholders' Equity             Capital stock   48,061,704  47,158,758        Contributed surplus   4,009,595  3,762,983        Options   10,209,388  8,915,059        Deficit   (52,893,897)  (46,931,555)          9,386,790  12,905,245          10,526,098  14,234,165
     
     
 Burcon NutraScience Corporation 
 Consolidated Statements of Operations and Comprehensive Loss 
 For the years ended March 31, 2012 and 2011 
     
  2012 2011
  $ $
 Expenses     
 General and administrative   5,061,510  6,055,351
 Research and development   1,040,085  2,889,853
     
 Loss from operations   (6,101,595)  (8,945,204)
     
 Interest and other income   139,253  138,730
     
 Loss and comp

(C) Copyright 2012 GlobeNewswire, Inc. All rights reserved.